The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Intrinsically disordered proteins are potential drug targets
Open accessAbstract
Intrinsically disordered (ID) proteins which lack stable secondary and tertiary structure in substantial regions (or throughout) are prevalent in eukaryotes. They exist as ensembles of rapidly fluctuating structures and many undergo coupled folding and binding reactions. Because ID proteins are overrepresented in major disease pathways they are desirable targets for inhibition, however, the feasibility of targeting proteins without defined structures was unclear. Recently, small molecules have been found which bind to the disordered regions of c-Myc, Aβ, EWS-Fli1, and various peptides. As with structured targets, initial hits were further optimized to increase specificity and affinity. Given the number and biological importance of ID proteins, the ability to inhibit their interactions opens tremendous potential in chemical biology and drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intrinsically unstructured proteins and their functions
Dyson, H. J., & Wright, P. E. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1589 · Cited by 3,871
A Hot Spot of Binding Energy in a Hormone-Receptor Interface
Clackson, T., & Wells, J. A. (1995) · Science · doi:10.1126/science.7529940 · Cited by 1,983
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
Intrinsically Disordered Proteins in Human Diseases: Introducing the D2Concept
Uversky, V. N., Oldfield, C. J., & Dunker, A. K. (2008) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.37.032807.125924 · Cited by 1,410
Understanding protein non-folding
Uversky, V. N., & Dunker, A. K. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.01.017 · Cited by 1,186
MYC oncogenes and human neoplastic disease
Nesbit, C. E., Tersak, J. M., & Prochownik, E. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202746 · Cited by 1,158
Transcriptional regulation and transformation by Myc proteins
Adhikary, S., & Eilers, M. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1703 · Cited by 1,131
Fuzzy complexes: polymorphism and structural disorder in protein–protein interactions
Tompa, P., & Fuxreiter, M. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.10.003 · Cited by 1,086
Wright, P. E., & Dyson, H. J. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.12.003 · Cited by 1,019
Function and structure of inherently disordered proteins
Dunker, A. K., Silman, I., Uversky, V. N., & Sussman, J. L. (2008) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.10.002 · Cited by 963
Drugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
Coller, H. A., Grandori, C., Tamayo, P., Colbert, T., Lander, E. S., Eisenman, R. N., & Golub, T. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3260 · Cited by 823
Modelling Myc inhibition as a cancer therapy
Soucek, L., Whitfield, J., Martins, C. P., Finch, A. J., Murphy, D. J., Sodir, N. M., Karnezis, A. N., Swigart, L. B., Nasi, S., & Evan, G. I. (2008) · Nature · doi:10.1038/nature07260 · Cited by 817
Prediction of Protein Binding Regions in Disordered Proteins
Mészáros, B., Simon, I., & Dosztányi, Z. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000376 · Cited by 627
The Myc oncoprotein as a therapeutic target for human cancer
Vita, M., & Henriksson, M. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.015 · Cited by 552
X-Ray Structures of Myc-Max and Mad-Max Recognizing DNA
Nair, S. K., & Burley, S. K. (2003) · Cell · doi:10.1016/s0092-8674(02)01284-9 · Cited by 551
Characterization of Molecular Recognition Features, MoRFs, and Their Binding Partners
Vacic, V., Oldfield, C. J., Mohan, A., Radivojac, P., Cortese, M. S., Uversky, V. N., & Dunker, A. K. (2007) · Journal of Proteome Research · doi:10.1021/pr0701411 · Cited by 483
Tight Regulation of Unstructured Proteins: From Transcript Synthesis to Protein Degradation
Gsponer, J., Futschik, M. E., Teichmann, S. A., & Babu, M. M. (2008) · Science · doi:10.1126/science.1163581 · Cited by 466
Strategies for Targeting Protein–Protein Interactions With Synthetic Agents
Yin, H., & Hamilton, A. D. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461786 · Cited by 453
Erkizan, H. V., Kong, Y., Merchant, M., Schlottmann, S., Barber-Rotenberg, J. S., Yuan, L., Abaan, O. D., Chou, T.-H., Dakshanamurthy, S., Brown, M. L., et al. (2009) · Nature Medicine · doi:10.1038/nm.1983 · Cited by 452
Low molecular weight inhibitors of Myc–Max interaction and function
Yin, X., Giap, C., Lazo, J. S., & Prochownik, E. V. (2003) · Oncogene · doi:10.1038/sj.onc.1206641 · Cited by 428
Predicting intrinsic disorder in proteins: an overview
He, B., Wang, K., Liu, Y., Xue, B., Uversky, V. N., & Dunker, A. K. (2009) · Cell Research · doi:10.1038/cr.2009.87 · Cited by 425
Protein dynamics and conformational disorder in molecular recognition
Mittag, T., Kay, L. E., & Forman‐Kay, J. D. (2010) · Journal of Molecular Recognition · doi:10.1002/jmr.961 · Cited by 418
Intrinsic disorder as a mechanism to optimize allosteric coupling in proteins
Hilser, V. J., & Thompson, E. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700329104 · Cited by 406
Xie, H., Vucetic, S., Iakoucheva, L. M., Oldfield, C. J., Dunker, A. K., Obradovic, Z., & Uversky, V. N. (2007) · Journal of Proteome Research · doi:10.1021/pr060394e · Cited by 382
Intrinsic Protein Disorder and Interaction Promiscuity Are Widely Associated with Dosage Sensitivity
Vavouri, T., Semple, J. I., Garcia-Verdugo, R., & Lehner, B. (2009) · Cell · doi:10.1016/j.cell.2009.04.029 · Cited by 368
Small Molecule Inhibitors of α-Synuclein Filament Assembly
Masuda, M., Suzuki, N., Taniguchi, S., Oikawa, T., Nonaka, T., Iwatsubo, T., Hisanaga, S.-I., Goedert, M., & Hasegawa, M. (2006) · Biochemistry · doi:10.1021/bi0600749 · Cited by 365
Biophysical characterization of intrinsically disordered proteins
Eliezer, D. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.12.004 · Cited by 328
Berg, T., Cohen, S. B., Desharnais, J., Sonderegger, C., Maslyar, D. J., Goldberg, J., Boger, D. L., & Vogt, P. K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062036999 · Cited by 326
Mining α-Helix-Forming Molecular Recognition Features with Cross Species Sequence Alignments
Cheng, Y., Oldfield, C. J., Meng, J., Romero, P., Uversky, V. N., & Dunker, A. K. (2007) · Biochemistry · doi:10.1021/bi7012273 · Cited by 323
Target Flexibility: An Emerging Consideration in Drug Discovery and Design
Cozzini, P., Kellogg, G. E., Spyrakis, F., Abraham, D. J., Costantino, G., Emerson, A., Fanelli, F., Gohlke, H., Kuhn, L. A., Morris, G. M., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800562d · Cited by 312
Substrate-targeting γ-secretase modulators
Kukar, T. L., Ladd, T. B., Bann, M. A., Fraering, P. C., Narlawar, R., Maharvi, G. M., Healy, B., Chapman, R., Welzel, A. T., Price, R. W., et al. (2008) · Nature · doi:10.1038/nature07055 · Cited by 280
Small-molecule aggregates inhibit amyloid polymerization
Feng, B. Y., Toyama, B. H., Wille, H., Colby, D. W., Collins, S. R., May, B. C. H., Prusiner, S. B., Weissman, J., & Shoichet, B. K. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.65 · Cited by 260
Intrinsic disorder in proteins associated with neurodegenerative diseases
Uversky, V. (2009) · Frontiers in Bioscience · doi:10.2741/3594 · Cited by 233
Multiple Independent Binding Sites for Small-Molecule Inhibitors on the Oncoprotein c-Myc
Hammoudeh, D. I., Follis, A. V., Prochownik, E. V., & Metallo, S. J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja900616b · Cited by 229
Self-citationRodi, D. J., Janes, R. W., Sanganee, H. J., Holton, R. A., Wallace, B. A., & Makowski, L. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2303 · Cited by 223
Malleable machines take shape in eukaryotic transcriptional regulation
Fuxreiter, M., Tompa, P., Simon, I., Uversky, V. N., Hansen, J. C., & Asturias, F. J. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.127 · Cited by 209
Mestres, J., Gregori-Puigjané, E., Valverde, S., & Solé, R. V. (2009) · Molecular BioSystems · doi:10.1039/b905821b · Cited by 203
Follis, A. V., Hammoudeh, D. I., Wang, H., Prochownik, E. V., & Metallo, S. J. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.09.011 · Cited by 183
Self-citationSelective Inhibition of c-Myc/Max Dimerization and DNA Binding by Small Molecules
Kiessling, A., Sperl, B., Hollis, A., Eick, D., & Berg, T. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.05.011 · Cited by 170
Cancer therapeutics: Targeting the dark side of Myc
Ponzielli, R., Katz, S., Barsyte-Lovejoy, D., & Penn, L. Z. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.017 · Cited by 168
Trapping Moving Targets with Small Molecules
Lee, G., & Craik, C. S. (2009) · Science · doi:10.1126/science.1169378 · Cited by 147
c-Myc as a therapeutic target in cancer
Prochownik, E. V. (2004) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.4.2.289 · Cited by 112
A credit-card library approach for disrupting protein–protein interactions
Xu, Y., Shi, J., Yamamoto, N., Moss, J. A., Vogt, P. K., & Janda, K. D. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.11.052 · Cited by 93
Selective Inhibition of c‐Myc/Max Dimerization by a Pyrazolo[1,5‐a]pyrimidine
Kiessling, A., Wiesinger, R., Sperl, B., & Berg, T. (2007) · ChemMedChem · doi:10.1002/cmdc.200600294 · Cited by 89
Discovery of Novel Myc−Max Heterodimer Disruptors with a Three-Dimensional Pharmacophore Model
Mustata, G. I., Follis, A. V., Hammoudeh, D. I., Metallo, S. J., Wang, H., Prochownik, E. V., Lazo, J. S., & Bahar, İ. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801278g · Cited by 85
Self-citationMo, H., & Arsenian‐Henriksson, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601418103 · Cited by 81
Detergent-like Interaction of Congo Red with the Amyloid β Peptide
Lendel, C., Bolognesi, B., Wahlström, A., Dobson, C. M., & Gräslund, A. (2010) · Biochemistry · doi:10.1021/bi902005t · Cited by 79
Structural disorder in amyloid fibrils: its implication in dynamic interactions of proteins
Tompa, P. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07250.x · Cited by 73
Small molecule inhibitors of Myc/Max dimerization and Myc-induced cell transformation
Jin, S. K., Stover, J. S., Whitby, L. R., Vogt, P. K., & Boger, D. L. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.09.044 · Cited by 63
Stabilizers of the Max Homodimer Identified in Virtual Ligand Screening Inhibit Myc Function
Jiang, H., Bower, K. E., Beuscher, A. E., Zhou, B., Bobkov, A. A., Olson, A. J., & Vogt, P. K. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.054858 · Cited by 62
Recombinant EWS-FLI1 Oncoprotein Activates Transcription
Üren, A., Tcherkasskaya, O., & Toretsky, J. A. (2004) · Biochemistry · doi:10.1021/bi048776q · Cited by 57
Myc Overexpression Enhances Apoptosis Induced by Small Molecules
Mo, H., Vita, M. F., Crespin, M., & Arsenian‐Henriksson, M. (2006) · Cell Cycle · doi:10.4161/cc.5.19.3320 · Cited by 37
Identification of a drug target motif: An anti-tumor drug NK109 interacts with a PNxxxxP
Morohashi, K., Yoshino, A., Yoshimori, A., Saito, S., Tanuma, S., Sakaguchi, K., & Sugawara, F. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.03.035 · Cited by 36
Camptothecin binds to a synthetic peptide identified by a T7 phage display screen
Takakusagi, Y., Kobayashi, S. S., & Sugawara, F. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.07.017 · Cited by 24
Nishiyama, K., Takakusagi, Y., Kusayanagi, T., Matsumoto, Y., Habu, S., Kuramochi, K., Sugawara, F., Sakaguchi, K., Takahashi, H., Natsugari, H., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.11.004 · Cited by 22
Aoki, S., Morohashi, K., Sunoki, T., Kuramochi, K., Kobayashi, S. S., & Sugawara, F. (2007) · Bioconjugate Chemistry · doi:10.1021/bc700287v · Cited by 21
Kodadek, T. J. (2002) · Biopolymers · doi:10.1002/bip.10233 · Cited by 16
The development of molecular clamps as drugs
Weiss, S. T., McIntyre, N. R., McLaughlin, M. L., & Merkler, D. J. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.011 · Cited by 11
Cited by
Classification of Intrinsically Disordered Regions and Proteins
van der Lee, R., Buljan, M., Lang, B., Weatheritt, R. J., Daughdrill, G. W., Dunker, A. K., Fuxreiter, M., Gough, J., Gsponer, J., Jones, D. T., et al. (2014) · Chemical Reviews · doi:10.1021/cr400525m · Cited by 2,174
Introducing Protein Intrinsic Disorder
Habchi, J., Tompa, P., Longhi, S., & Uversky, V. N. (2014) · Chemical Reviews · doi:10.1021/cr400514h · Cited by 756
α-Synuclein misfolding and Parkinson's disease
Breydo, L., Wu, J. W., & Uversky, V. N. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.002 · Cited by 657
Intrinsically disordered proteins: a 10-year recap
Tompa, P. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.08.004 · Cited by 631
Intrinsically disordered proteins: regulation and disease
Babu, M. M., van der Lee, R., de Groot, N. S., & Gsponer, J. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.03.011 · Cited by 601
Metadata
- Authors
- Metallo, S. J.
- Venue
- Current Opinion in Chemical Biology
- Publisher
- Elsevier BV
- Published
- 2010-08
- Volume
- 14
- Issue
- 4
- Pages
- 481-488
- ISSN
- 1367-5931 (ISSN-L)
- OpenAlex
- W2084652316
- Cited by
- 303
- References
- 60
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.